To identify the RNA editing events that best distinguished the tumor samples (ER+, TNBC) from their adjacent, non-cancerous counterparts, we first filtered the sites to include only those detected in at least 40% of either the control samples or the corresponding cancer samples. Here, ESR1 is linked to cancer.